Taketo Makoto Mark
Department of Pharmacology, Graduate School of Medicine, Kyoto University, Yoshida-Konoé-cho, Sakyo, Kyoto 606-8501, Japan.
Cancer Sci. 2006 May;97(5):355-61. doi: 10.1111/j.1349-7006.2006.00190.x.
The laboratory mouse (Mus musculus) has become one of the best model animal species in biomedical research today because of its abundant genetic/genomic information, and easy mutagenesis using transgenic and gene knockout technology. Genetically engineered mice have become essential tools in both mechanistic studies and drug development. In this article I will review recent topics in gastrointestinal cancer model mice, with emphasis on the results obtained in our laboratory. They include: (i) mouse models for familial adenomatous polyposis (Apc mutant mice; modifier genes of Apc intestinal polyposis; stabilizing beta-catenin mutant mice); (ii) mouse models for colon cancer (mouse models for hereditary non-polyposis colon cancer; additional mutations in Apc mutant mice; models with mutations in other genes; models for colon cancer associated with inflammatory bowel diseases); and (iii) mouse models for gastric cancer.
实验室小鼠(小家鼠)因其丰富的遗传/基因组信息以及利用转基因和基因敲除技术进行简易诱变,已成为当今生物医学研究中最佳的模式动物物种之一。基因工程小鼠已成为机制研究和药物开发的重要工具。在本文中,我将综述胃肠道癌模型小鼠的近期研究主题,重点介绍我们实验室所取得的成果。它们包括:(i)家族性腺瘤性息肉病的小鼠模型(Apc突变小鼠;Apc肠道息肉病的修饰基因;稳定型β-连环蛋白突变小鼠);(ii)结肠癌的小鼠模型(遗传性非息肉病性结肠癌的小鼠模型;Apc突变小鼠中的其他突变;其他基因突变的模型;与炎症性肠病相关的结肠癌模型);以及(iii)胃癌的小鼠模型。